Brian D. Kelley

ORCID: 0000-0002-1205-1804
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Protein purification and stability
  • Viral Infectious Diseases and Gene Expression in Insects
  • Monoclonal and Polyclonal Antibodies Research
  • Hemophilia Treatment and Research
  • Biosimilars and Bioanalytical Methods
  • Virus-based gene therapy research
  • Analytical Chemistry and Chromatography
  • Transgenic Plants and Applications
  • Solar Thermal and Photovoltaic Systems
  • Chemical and Physical Properties in Aqueous Solutions
  • Glycosylation and Glycoproteins Research
  • CAR-T cell therapy research
  • Surfactants and Colloidal Systems
  • Microfluidic and Capillary Electrophoresis Applications
  • Animal Genetics and Reproduction
  • Hybrid Renewable Energy Systems
  • Mass Spectrometry Techniques and Applications
  • Innovative Microfluidic and Catalytic Techniques Innovation
  • Parvovirus B19 Infection Studies
  • Advanced Biosensing Techniques and Applications
  • Diverse Music Education Insights
  • Electrophoretic Deposition in Materials Science
  • Enzyme-mediated dye degradation
  • Escherichia coli research studies
  • Temporomandibular Joint Disorders

VIR Biotechnology (United States)
2018-2024

University of North Texas
2022

UW Health University Hospital
2021

La Roche College
2015

Louisiana State University
2006-2013

Kodak (United Kingdom)
2006

Andover Eye Associates
1993-2001

Amgen (United States)
1998

Massachusetts Institute of Technology
1993

Biotechnology Institute
1990

10.1038/s41587-020-0512-5 article EN Nature Biotechnology 2020-04-21

Abstract The development of purification processes for protein biopharmaceuticals is challenging due to compressed timelines, long experimental times, and the need survey a large parameter space. Typical methods chromatography step evaluate several dozen chromatographic column runs optimize conditions. An efficient batch‐binding method screening conditions in 96‐well format with robotic liquid‐handling system described evaluated. dispenses slurries resins into filter plates, which are then...

10.1002/bit.21904 article EN Biotechnology and Bioengineering 2008-03-20

Weak partitioning chromatography (WPC) is an isocratic chromatographic protein separation method performed under mobile phase conditions where a significant amount of the product binds to resin, well in excess typical flowthrough operations. The more stringent load and wash lead improved removal tightly binding impurities, although at cost reduction step yield. yield can be restored by extending column incorporating short end stage. use WPC with anion exchange resins enables two-column cGMP...

10.1002/bit.21923 article EN Biotechnology and Bioengineering 2008-04-03

Ion-exchange (IEX) chromatography steps are widely applied in protein purification processes because of their high capacity, selectivity, robust operation, and well-understood principles. Optimization IEX typically involves resin screening selection the pH counterion concentrations load, wash, elution steps. Time material constraints associated with operating laboratory columns often preclude evaluating more than 20-50 conditions during early stages process development. To overcome this...

10.1002/bit.21905 article EN Biotechnology and Bioengineering 2008-03-20

Abstract A high‐throughput screen (HTS) was developed to evaluate the selectivity of various hydrophobic interaction chromatography (HIC) resins for separating a mAb from aggregate species. Prior resin screen, solubility protein assessed determine allowable HIC operating region by examining 384 combinations pH, salt, and concentration. The then incorporated 480 batch‐binding elution conditions with eight in combination six salts. results were reproducible, demonstrated quantitative recovery...

10.1002/bit.21907 article EN Biotechnology and Bioengineering 2008-03-20

Therapeutic monoclonal antibody (mAb) development and the processes for manufacturing drug substance have evolved since first approval of mAb in 1986. As past is often prologue to future, history these technologies has been classified here into three eras, leading speculation about what next era may hold with regard strategies, as well potential impacts patients. The substantial increase production culture titers bioreactor volumes availability large-scale contract facilities could translate...

10.1080/19420862.2024.2373330 article EN cc-by-nc mAbs 2024-07-01

Factor VIII-specific affibodies were selected from phage displayed libraries constructed by combinatorial mutagenesis of an alpha helical bacterial receptor domain derived staphylococcal protein A. Bead-immobilized recombinant human factor VIII (rVIII) (80 and 90 kDa chains) was used during competitive biopannings in the presence free 80-kDa chain protein, resulting selection several binders that showed dissociation constants (Kd) range 100-200 nM as determined biosensor analyses. One...

10.1046/j.1432-1327.2001.02344.x article EN European Journal of Biochemistry 2001-08-01

Abstract The effect of typical contaminants in inclusion body preparations such as DNA, ribosomal RNA, phospholipids, lipopolysaccharides, and other proteins on renaturation rate yield hen egg white lysozyme was investigated. Separate experiments were conducted which known amounts individual added to test their kinetics. On the basis a simplified model for kinetic competition between folding aggregation, it found that none above had an reaction, but some them significantly affected...

10.1021/bp970008l article EN Biotechnology Progress 1997-01-01

Abstract High‐throughput screening (HTS) of chromatography resins for identifying optimal protein purification conditions is becoming an integral part industrial process development. In this work, ceramic hydroxyapatite (cHA) 15 humanized monoclonal antibodies (mAbs) was examined by HTS. MAb binding, as quantified partition coefficient ( K p ), measured under 92 combinations sodium chloride, phosphate, and pH. Binding varied inversely with these variables all mAbs tested. However, the...

10.1002/bit.21906 article EN Biotechnology and Bioengineering 2008-03-19

Formulation of protein biopharmaceuticals as highly concentrated liquids can improve the drug substance storage and supply chain, target product profile, allow greater flexibility in dosing methods. The Donnan effect cause a large offset pH from value established with diafiltration buffer during concentration charged proteins ultrafiltration membranes. For neutral formulations, will typically increase above for basic monoclonal antibodies decline below acidic Fc-fusion proteins. In this...

10.1002/btpr.523 article EN Biotechnology Progress 2010-10-13

Affinity cosurfactants, consisting of hydrophilic ligands derivatized with hydrophobic tails, increase the efficiency selective protein recoveries using reversed micelles by extending operating range pH and salt concentration over which an extraction can be performed. Three different affinity cosurfactant-protein pairs have been used to demonstrate principles this extractive technique: (i) concanavalin A, a lectin, was extracted addition octyl glucoside; (ii) natural amphiphiles, such as...

10.1002/bit.260421010 article EN Biotechnology and Bioengineering 1993-11-20
Coming Soon ...